Product Code: ETC12626264 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
According to 6Wresearch internal database and industry insights, the denmark oncology anti-cancer drugs market was valued at USD Increasing prevalence of cancer in Denmark Billion in 2024 and is expected to reach USD Technological advancements in oncology treatments Billion by 2031, growing at a compound annual growth rate of Growing investments in research and development of anti-cancer drugs during the forecast period (2025-2031).
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Denmark Oncology Anti-Cancer Drugs Market Overview |
3.1 Denmark Country Macro Economic Indicators |
3.2 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Denmark Oncology Anti-Cancer Drugs Market - Industry Life Cycle |
3.4 Denmark Oncology Anti-Cancer Drugs Market - Porter's Five Forces |
3.5 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.9 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Denmark Oncology Anti-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Denmark Oncology Anti-Cancer Drugs Market Trends |
6 Denmark Oncology Anti-Cancer Drugs Market, By Types |
6.1 Denmark Oncology Anti-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.4 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.5 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.1.6 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.1.7 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
6.2 Denmark Oncology Anti-Cancer Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021 - 2031F |
6.2.5 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.6 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.3 Denmark Oncology Anti-Cancer Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.4 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.5 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Topical, 2021 - 2031F |
6.3.6 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4 Denmark Oncology Anti-Cancer Drugs Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.4.3 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.4.4 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.4.5 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.4.6 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5 Denmark Oncology Anti-Cancer Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5.4 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.5 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.5.6 Denmark Oncology Anti-Cancer Drugs Market Revenues & Volume, By Mail Order Pharmacies, 2021 - 2031F |
7 Denmark Oncology Anti-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Denmark Oncology Anti-Cancer Drugs Market Export to Major Countries |
7.2 Denmark Oncology Anti-Cancer Drugs Market Imports from Major Countries |
8 Denmark Oncology Anti-Cancer Drugs Market Key Performance Indicators |
9 Denmark Oncology Anti-Cancer Drugs Market - Opportunity Assessment |
9.1 Denmark Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Denmark Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Denmark Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Denmark Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.5 Denmark Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Denmark Oncology Anti-Cancer Drugs Market - Competitive Landscape |
10.1 Denmark Oncology Anti-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Denmark Oncology Anti-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |